Copyright © 1997 by the European Society of Cardiology.
© 1997 The European Society of Cardiology
EUROASPIRE
A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results
EUROASPIRE Study GroupReceived 1 May 1997; accepted 20 June 1997.
Correspondence: Professor D. A. Wood, Cardiac Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, Dovehouse Street, London SW3 6LY
Abstract
BACKGROUND: The three major European scientific societies in cardiovascular medicine—the European Society of Cardiology (ESC), the European Atherosclerosis Society and the European Society of Hypertension—published in October 1994 joint recommendations on prevention of coronary heart disease in clinical practice. Patients with established coronary heart disease, or other major atherosclerotic disease, were deemed to be the top priority for prevention. A European survey (EUROASPIRE) was therefore conducted under the auspices of the ESC to describe current clinical practice in relation to secondary prevention of coronary heart disease.
AIMS: The aims of EUROASPIRE were (i) to determine whether the major risk factors for coronary heart disease are recorded in patients medical records; (ii) to measure the modifiable risk factors and describe their current management following hospitalization, and (ii) to determine whether first degree blood relatives have been screened.
MEHTODS: The survey was conducted in selected geographical areas and hospitals in nine European countries. Consecutive patients (
70 years) were identified retrospectively with the following diagnoses: coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, acute myocardial infarction and acute myocardial ischaemia without infarction. Data collection was based on a retrospective review of hospital medical records and a prospective interview and examination of the patients.
RESULTS: 4863 medical records were reviewed of whom 25% were women, and 3569 patients were interviewed (adjusted response rate 85%) with an average age of 61 years. Nineteen percent of patients smoked cigarettes, 25% were overweight (BMI 
30 kg. m–2), 53% had raised blood pressure (systolic BP 140 and/or diastolic BP 90 mmHg), 44% had raised total plasma cholesterol (total cholesterol 5·5 mmol . l–1) and 18% were diabetic. Reported medication at interview was: antiplatelet drugs 81%, beta-blockers, 54% (58% in post-infarction patients). ACE inhibitors 30% (38% in post infarction patients) and lipid lowering drugs 32%. Of the patients receiving blood pressure lowering drugs (not always prescribed for the treatment of hypertension) 50% had a systolic BP <140 mmHg and 21% <160 mmHg, and of those receiving lipid lowering drugs, 49% had plasma total cholesterol <5·5 mmol. l–1 and 13% <6·5 mmol. l–1. Thirty-seven percent of patients had a family history of premature coronary heart disease in a first-degree blood relative, but only 21% of patients reported being advised to have their relatives screened for coronary risk factors.
CONCLUSIONS: This European survey has demonstrated a high prevalence of modifiable risk factors in coronary heart disease patients. There is considerable potential for cardiologists and physicians to further reduce coronary heart disease morbidity and mortality and improve patients chances of survival
Key Words: EUROASPIRE • coronary heart disease • risk factors • secondary prevention
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S Capewell and M O'Flaherty Maximising secondary prevention therapies in patients with coronary heart disease Heart, January 1, 2008; 94(1): 8 - 9. [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backer, S. Ebrahim, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) Eur. Heart J., October 1, 2007; 28(19): 2375 - 2414. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dumont, M. Zureik, C. Bauters, M.-C. Grupposo, D. Cottel, M. Montaye, M. Hamon, P. Ducimetiere, P. Amouyel, and T. Brousseau Association of OAZ1 Gene Polymorphisms With Subclinical and Clinical Vascular Events Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2120 - 2126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dumont, M. Zureik, D. Cottel, M. Montaye, P. Ducimetiere, P. Amouyel, and T. Brousseau Association of arginase 1 gene polymorphisms with the risk of myocardial infarction and common carotid intima media thickness J. Med. Genet., August 1, 2007; 44(8): 526 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Erdmann, J. A. Dormandy, B. Charbonnel, M. Massi-Benedetti, I. K. Moules, A. M. Skene, and on behalf of the PROactive Investigators The Effect of Pioglitazone on Recurrent Myocardial Infarction in 2,445 Patients With Type 2 Diabetes and Previous Myocardial Infarction: Results From the PROactive (PROactive 05) Study J. Am. Coll. Cardiol., May 1, 2007; 49(17): 1772 - 1780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Wood The concept of doctor targets based on quality guidelines: focus on blood pressure Eur. Heart J. Suppl., May 1, 2007; 9(suppl_B): B29 - B36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B S Rana, J I Davies, M M Band, S D Pringle, A Morris, and A D Struthers B-type natriuretic peptide can detect silent myocardial ischaemia in asymptomatic type 2 diabetes Heart, July 1, 2006; 92(7): 916 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. H. Gislason, J. N. Rasmussen, S. Z. Abildstrom, N. Gadsboll, P. Buch, J. Friberg, S. Rasmussen, L. Kober, S. Stender, M. Madsen, et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction Eur. Heart J., May 2, 2006; 27(10): 1153 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Scholte op Reimer, E. de Swart, D. De Bacquer, K. Pyorala, U. Keil, J. Heidrich, J. W. Deckers, K. Kotseva, D. Wood, E. Boersma, et al. Smoking behaviour in European patients with established coronary heart disease Eur. Heart J., January 1, 2006; 27(1): 35 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Diamantopoulos, V. G. Athyros, G. K. Yfanti, E. N. Migdalis, M. Elisaf, P. E. Vardas, A. S. Manolis, D. T. Karamitsos, E. S. Ganotakis, D. Hatseras, et al. The contrOL of dYslipideMia in outPatIent clinics in GreeCe (Olympic) Study Angiology, November 1, 2005; 56(6): 731 - 741. [Abstract] [PDF]
|
|
|
|
|
|
C. Ballantyne, B. Arroll, and J. Shepherd Lipids and CVD management: towards a global consensus Eur. Heart J., November 1, 2005; 26(21): 2224 - 2231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Wood Guidelines on cardiovascular risk assessment and management Eur. Heart J. Suppl., November 1, 2005; 7(suppl_L): L5 - L10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Bassand, S. Priori, and M. Tendera Evidence-based vs. 'impressionist' medicine: how best to implement guidelines Eur. Heart J., June 2, 2005; 26(12): 1155 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S J Leslie, S P McKee, E A Imray, and M A Denvir Management of chronic heart failure: perceived needs of general practitioners in light of the new general medical services contract Postgrad. Med. J., May 1, 2005; 81(955): 321 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K F Carruthers, O H Dabbous, M D Flather, I Starkey, A Jacob, D MacLeod, K A A Fox, and on behalf of the GRACE Investigators Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE) Heart, March 1, 2005; 91(3): 290 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Khanderia, K. A. Townsend, K. Eagle, and R. Prager Statin Initiation Following Coronary Artery Bypass Grafting: Outcome of a Hospital Discharge Protocol Chest, February 1, 2005; 127(2): 455 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-B. Leu, C.-P. Lin, W.-T. Lin, T.-C. Wu, and J.-W. Chen Risk Stratification and Prognostic Implication of Plasma Biomarkers in Nondiabetic Patients With Stable Coronary Artery Disease: The Role of High-Sensitivity C-Reactive Protein Chest, October 1, 2004; 126(4): 1032 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.D.R. Hobbs Guidelines and management of global risk: the European perspective Eur. Heart J. Suppl., July 1, 2004; 6(suppl_C): C5 - C14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O Mayer Jr, J Simon, J Heidrich, D V Cokkinos, and D De Bacquer Educational level and risk profile of cardiac patients in the EUROASPIRE II substudy J. Epidemiol. Community Health, January 1, 2004; 58(1): 47 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Devroey, P Coigniez, J Vandevoorde, J Kartounian, and W Betz Prevention and follow-up of cardiovascular disease among patients without a personal GP Fam. Pract., August 1, 2003; 20(4): 420 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R F Redberg Are there sex differences in risk factors for coronary heart disease? Maternal versus paternal transmission Heart, August 1, 2003; 89(8): 817 - 818. [Full Text] [PDF]
|
|
|
|
 |
|
 A. T Erkkila, S. Lehto, K. Pyorala, and M. I. Uusitupa n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease Am. J. Clinical Nutrition, July 1, 2003; 78(1): 65 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Unal, J A Critchley, and S Capewell Missing, mediocre, or merely obsolete? An evaluation of UK data sources for coronary heart disease J. Epidemiol. Community Health, July 1, 2003; 57(7): 530 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fischer, A. Baessler, H.W. Hense, C. Hengstenberg, M. Muscholl, S. Holmer, A. Doring, U. Broeckel, G. Riegger, and H. Schunkert Prevalence of left ventricular diastolic dysfunction in the community: Results from a Doppler echocardiographic-based survey of a population sample Eur. Heart J., February 2, 2003; 24(4): 320 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Hobbs and L. Erhardt Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey Fam. Pract., December 1, 2002; 19(6): 596 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Amar, B Chamontin, J Ferrieres, N Danchin, O Grenier, C Cantet, and J-P Cambou Hypertension control at hospital discharge after acute coronary event: influence on cardiovascular prognosis--the PREVENIR study Heart, December 1, 2002; 88(6): 587 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mosca C-Reactive Protein -- To Screen or Not to Screen? N. Engl. J. Med., November 14, 2002; 347(20): 1615 - 1617. [Full Text] [PDF]
|
|
|
|
|
|
P Tyden, O Hansen, G Engstrom, B Hedblad, and L Janzon Myocardial infarction in an urban population: worse long term prognosis for patients from less affluent residential areas J. Epidemiol. Community Health, October 1, 2002; 56(10): 785 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Rea, S. R. Heckbert, R. C. Kaplan, N. L. Smith, R. N. Lemaitre, and B. M. Psaty Smoking Status and Risk for Recurrent Coronary Events after Myocardial Infarction Ann Intern Med, September 17, 2002; 137(6): 494 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Underwood and P Beck Secondary prevention following myocardial infarction: evidence from an audit in South Wales that the National Service Framework for coronary heart disease does not address all the issues Qual. Saf. Health Care, September 1, 2002; 11(3): 230 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.D.R. Hobbs What should cardiologists be telling general practitioners/family physicians? Eur. Heart J. Suppl., September 1, 2002; 4(suppl_F): F54 - F59. [Abstract] [PDF]
|
|
|
|
|
|
K. A. A. Fox, S. G. Goodman, W. Klein, D. Brieger, P. G. Steg, O. Dabbous, A. Avezum, and GRACE Investigators Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE) Eur. Heart J., August 1, 2002; 23(15): 1177 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Danchin, O Grenier, J Ferrieres, C Cantet, and J-P Cambou Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: results from the nationwide French PREVENIR survey Heart, August 1, 2002; 88(2): 159 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P G Steg, B Iung, L J Feldman, D Cokkinos, J Deckers, K A A Fox, U Keil, and A P Maggioni Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes Heart, July 1, 2002; 88(1): 20 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gandjour, F. Kleinschmit, K.W. Lauterbach, and INTERCARE Iternational Investigators European comparison of costs and quality in the treatment of acute myocardial infarction (2000-2001) Eur. Heart J., June 1, 2002; 23(11): 858 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Egred and L. Corr Establishment and feasibility of community-based general-practitioner-led cardiology clinics QJM, May 1, 2002; 95(5): 299 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.R. Cowie Coronary risk--time for a more sophisticated approach? Eur. Heart J., April 2, 2002; 23(8): 589 - 591. [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Patrick, T. Kosoglou, K. L. Stauber, K. B. Alton, S. E. Maxwell, Y. Zhu, P. Statkevich, R. Iannucci, S. Chowdhury, M. Affrime, et al. Disposition of the Selective Cholesterol Absorption Inhibitor Ezetimibe in Healthy Male Subjects Drug Metab. Dispos., April 1, 2002; 30(4): 430 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. de Lorgeril, P. Salen, P. Defaye, P. Mabo, and F. Paillard Dietary prevention of sudden cardiac death Eur. Heart J., February 2, 2002; 23(4): 277 - 285. [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Qureshi, M. F. K. Suri, L. R. Guterman, and L. N. Hopkins Ineffective Secondary Prevention in Survivors of Cardiovascular Events in the US Population: Report From the Third National Health and Nutrition Examination Survey Arch Intern Med, July 9, 2001; 161(13): 1621 - 1628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Baessler, C Hengstenberg, S Holmer, M Fischer, B Mayer, U Hubauer, G Klein, G Riegger, and H Schunkert Long-term effects of in-hospital cardiac rehabilitation on the cardiac risk profile. A case-control study in pairs of siblings with myocardial infarction Eur. Heart J., July 1, 2001; 22(13): 1111 - 1118. [Abstract] [PDF]
|
|
|
|
|
|
L Wilhelmsen, K Pyorala, H Wedel, T Cook, T Pedersen, J Kjekshus, and for the 4S Study Group Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment Eur. Heart J., July 1, 2001; 22(13): 1119 - 1127. [Abstract] [PDF]
|
|
|
|
|
|
H. Rosolova and J. Simon Are the data on trends in case-fatality in patients with acute myocardial infarction observed in Scotland applicable across Europe? Eur. Heart J., June 2, 2001; 22(12): 979 - 980. [PDF]
|
|
|
|
|
|
H.M. Krumholz Gaps and opportunities in the practice of medicine: the need for improved systems of care Eur. Heart J., June 1, 2001; 22(11): 889 - 890. [PDF]
|
|
|
|
|
|
C Hengstenberg, S.R Holmer, B Mayer, S Engel, A Schneider, H Lowel, G.A.J Riegger, and H Schunkert Siblings of myocardial infarction patients are overlooked in primary prevention of cardiovascular disease Eur. Heart J., June 1, 2001; 22(11): 926 - 933. [Abstract] [PDF]
|
|
|
|
|
|
P.J Schreiner, M Niemela, H Miettinen, M Mahonen, M Ketonen, P Immonen-Raiha, S Lehto, T Vuorenmaa, P Palomaki, H Mustaniemi, et al. Gender differences in recurrent coronary events. The FINMONICA MI register Eur. Heart J., May 1, 2001; 22(9): 762 - 768. [Abstract] [PDF]
|
|
|
|
|
|
I S Malik, V K Bhatia, and J S Kooner Cost effectiveness of ramipril treatment for cardiovascular risk reduction Heart, May 1, 2001; 85(5): 539 - 543. [Abstract] [Full Text]
|
|
|
|
|
|
Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme Eur. Heart J., April 1, 2001; 22(7): 554 - 572. [Abstract] [PDF]
|
|
|
|
|
|
A. T Erkkila, E. S Sarkkinen, V. Lindi, S. Lehto, M. Laakso, and M. I. Uusitupa APOE polymorphism and the hypertriglyceridemic effect of dietary sucrose Am. J. Clinical Nutrition, April 1, 2001; 73(4): 746 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Shepherd The statin era: in search of the ideal lipid regulating agent Heart, March 1, 2001; 85(3): 259 - 264. [Full Text]
|
|
|
|
|
|
K. Orth-Gomer Coronary risk factor modification after the acute event--why are effects not maintained? Eur. Heart J., February 2, 2001; 22(4): 276 - 279. [PDF]
|
|
|
|
|
|
S.N Willich, J Muller-Nordhorn, M Kulig, S Binting, H Gohlke, H Hahmann, K Bestehorn, K Krobot, and H Voller Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease. A prospective cohort study Eur. Heart J., February 2, 2001; 22(4): 307 - 313. [Abstract] [PDF]
|
|
|
|
|
|
C. A. Jackevicius, G. M. Anderson, L. Leiter, and J. V. Tu Use of the Statins in Patients After Acute Myocardial Infarction: Does Evidence Change Practice? Arch Intern Med, January 22, 2001; 161(2): 183 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Monkman Treating dyslipidaemia in primary care BMJ, November 25, 2000; 321(7272): 1299 - 1300. [Full Text]
|
|
|
|
|
|
A. Batalla, S. Hevia, J. R. Reguero, and G. I. Cubero Underutilization of Lipid-Lowering Therapy in Coronary Artery Disease Arch Intern Med, September 25, 2000; 160(17): 2683 - 2684. [Full Text] [PDF]
|
|
|
|
|
|
R. T. van Domburg, K. Meeter, D. F. M. van Berkel, R. F. Veldkamp, L. A. van Herwerden, and A. J. J. C. Bogers Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study J. Am. Coll. Cardiol., September 1, 2000; 36(3): 878 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.A.A Fox, D.V Cokkinos, J Deckers, U Keil, A Maggioni, and G Steg The ENACT study: a pan-European survey of acute coronary syndromes Eur. Heart J., September 1, 2000; 21(17): 1440 - 1449. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. PEKER, J. HEDNER, H. KRAICZI, and S. LÖTH Respiratory Disturbance Index . An Independent Predictor of Mortality in Coronary Artery Disease Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 81 - 86. [Abstract] [Full Text]
|
|
|
|
|
|
C. Brotons and J. Soler-Soler Obesity, Cinderella of CHD risk factors Eur. Heart J., May 2, 2000; 21(10): 793 - 795. [PDF]
|
|